CRL
Charles River Laboratories International, Inc.
Stock
$290.19+3.36 (+1.17%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $743M
- YoY, 2025
- −1.1%
- 5-year CAGR
- +7.0%
- 10-year CAGR
- +9.5%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $743M | −1.1% |
| 2024 | $751M | +0.4% |
| 2023 | $748M | +12.4% |
| 2022 | $665M | +7.3% |
| 2021 | $620M | +17.2% |
| 2020 | $529M | +2.2% |
| 2019 | $518M | +16.6% |
| 2018 | $444M | +19.6% |
| 2017 | $371M | +1.8% |
| 2016 | $365M | +21.4% |
| 2015 | $300M | +11.7% |
| 2014 | $269M | +19.2% |
| 2013 | $226M | +8.4% |
| 2012 | $208M | +4.8% |
| 2011 | $199M | −14.6% |
| 2010 | $232M | +2.1% |
| 2009 | $228M | +1.7% |
| 2008 | $224M | — |